Assessment of posaconazole salvage therapy in chronic pulmonary aspergillosis by using predefined response criteria

Chronic pulmonary aspergillosis (CPA) is a slowly progressive infection mainly caused by Aspergillus fumigatus, characterized by inflammatory destruction of lung tissue with cavitation, pleural thickening and/or fibrosis, and associated with significant respiratory and constitutional symptoms [1 –3]. CPA usually affects patients with underlying structural airway disease with air-filled cavities or bullae, such as tuberculosis (TB), non-tuberculous mycobacterial infection, chronic obstructive pulmonary disease (COPD), allergic bronchopulmonary aspergillosis (ABPA), pneumothorax and sarcoid osis.
Source: International Journal of Antimicrobial Agents - Category: Drugs & Pharmacology Authors: Source Type: research

Related Links:

Rapid CommunicationRiley Hazard, Kyle B. Enfield, Darla J. Low, Eve T. Giannetta, Costi D. Sifri,Infection Control&Hospital Epidemiology,Volume 37 Issue 09, pp 1111-1113Abstract
Source: Infection Control and Hospital Epidemiology - Category: Epidemiology Source Type: research
Helmut J. F. Salzer, Juergen Prattes, Martin Hoenigl
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research
Unfortunately, the Acknowledgements section was not included in the original version of the article. The said section is given here.
Source: European Journal of Clinical Microbiology and Infectious Diseases - Category: Microbiology Source Type: research
AbstractTuberculosis, smoking, and alcohol drinking are major public health and social issues worldwide. We investigated the joint effect of smoking plus alcohol drinking on TB treatment. Retrospective study was conducted among TB patients in 49  units from eight provinces in China. All patients enrolled were classified into four groups according to their smoking and/or alcohol status. Current smokers plus drinkers belonged to group 1; ex-smokers plus ex-drinkers were in group 2; current smokers and ex-drinkers, current smokers and never d rinkers, ex-smokers and current drinkers, ex-smokers and never drinkers, never ...
Source: European Journal of Clinical Microbiology and Infectious Diseases - Category: Microbiology Source Type: research
In this study, the semiconductor photocatalyst zinc oxide (ZnO) was used to impregnate on Aspergillus carbonarius (AC) and Penicillium glabrum (PG) fungi for photocatalytic oxidation of azo dye solutions. The photocatalytic decolorization of two textile dyes, Basic Red 18 (BR18) and Reactive Red 180 (RR180), was investigated and the impact of catalyst loading as well as initial dye concentration was systematically examined. Complete decolorization of BR18 was obtained by ZnO impregnated Aspergillus carbonarius (ZnO/AC) and Penicillium glabrum (ZnO/PG). The results also showed that the highest RR180 decolorization levels we...
Source: Biochemical Engineering Journal - Category: Biochemistry Source Type: research
Condition:   Asthma-COPD Overlap Syndrome Interventions:   Drug: Cholecalciferol;   Other: Placebo oral capsule Sponsor:   Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Tuberculosis;   Pediatric ALL;   Behavior, Health Intervention:   Behavioral: Increasing the completion of IPT Sponsor:   Universidad Peruana Cayetano Heredia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Tue, 03/19/2019 - 08:24News blog
Source: The Aspergillus Website - updates - Category: Respiratory Medicine Authors: Source Type: news
Chronic pulmonary aspergillosis (CPA) is a slowly progressive infection mainly caused by Aspergillus fumigatus, characterized by inflammatory destruction of lung tissue with cavitation, pleural thickening and/or fibrosis, and associated with significant respiratory and constitutional symptoms [1 –3]. CPA usually affects patients with underlying structural airway disease with air-filled cavities or bullae, such as tuberculosis (TB), non-tuberculous mycobacterial infection, chronic obstructive pulmonary disease (COPD), allergic bronchopulmonary aspergillosis (ABPA), pneumothorax and sarcoid osis.
Source: International Journal of Antimicrobial Agents - Category: Drugs & Pharmacology Authors: Source Type: research
More News: Allergy & Immunology | Aspergillosis | Aspergillus | Chronic Obstructive Pulmonary | Drugs & Pharmacology | Pneumothorax | Respiratory Medicine | Sarcoidosis | Tuberculosis